Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$16.45 - $25.88 $639,905 - $1.01 Million
-38,900 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$22.67 - $28.01 $564,483 - $697,449
24,900 Added 177.86%
38,900 $980,000
Q3 2021

Nov 16, 2021

SELL
$29.97 - $36.66 $263,736 - $322,607
-8,800 Reduced 38.6%
14,000 $452,000
Q2 2021

Aug 16, 2021

BUY
$25.39 - $32.61 $289,446 - $371,754
11,400 Added 100.0%
22,800 $697,000
Q1 2021

May 18, 2021

SELL
$19.92 - $31.6 $378,480 - $600,400
-19,000 Reduced 62.5%
11,400 $347,000
Q4 2020

Feb 17, 2021

BUY
$12.16 - $19.77 $154,432 - $251,079
12,700 Added 71.75%
30,400 $601,000
Q3 2020

Nov 17, 2020

SELL
$11.25 - $14.75 $56,250 - $73,750
-5,000 Reduced 22.03%
17,700 $231,000
Q2 2020

Aug 17, 2020

BUY
$10.69 - $16.49 $242,663 - $374,322
22,700 New
22,700 $257,000
Q1 2020

May 15, 2020

SELL
$9.78 - $29.53 $202,446 - $611,271
-20,700 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$20.93 - $35.1 $433,251 - $726,570
20,700 New
20,700 $564,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.